Extracorporeal photopheresis (ECP or photopheresis) is an advanced therapeutic apheresis
procedure in which blood is separated into its various components and the isolated buffy …

Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy based upon pheresis of light‐sensitive cells. Whole blood is removed from patients …

Extracorporeal phototherapy (ECP) is a therapeutic approach based on the biological effect
of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet light A (UVA) on mononuclear cells …

Extracorporeal photopheresis (ECP) is a combination of leukapheresis and photodynamic
therapy in which blood is treated with photoactivable drugs which are then activated with …

Extracorporeal photopheresis (ECP) has had a major impact in the treatment of various
conditions in the past 25 years. Although it was initially developed for the treatment of …

Extracorporeal photopheresis is a new form of immunotherapy that involves the use of a
leukapheresis device that permits the extracorporeal exposure of potentially pathogenic …

Photochemotherapy and leukapheresis are combined in a new treatment procedure termed
photopheresis [1, 2]. In this therapy patients ingest 8 methoxypsoralen (8MOP) and 1-2 …

Extracorporeal photopheresis (ECP) is a cell-based immunotherapy that involves the
reinfusion of autologous leukocytes after exposure to psoralen and UVA. The treatment has …

Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …

Extracorporeal photopheresis (ECP) has gained importance in the treatment of several
diseases. Initially introduced as a new therapeutic modality for the treatment of patients with …